SU101: Filed IND for a Phase I trial

Sugen Inc. (SUGN), Redwood City, Calif. Product: SU101 synthetic small molecule inhibitor of the receptor for platelet-derived growth factor (PDGF) Indication: Solid tumors including glioblastoma and ...